Validation of a static Franz diffusion cell system for in vitro permeation studies

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1432-1441

  Ng, Shiow Fern ^a   Rouse, Jennifer J ^b   Sanderson, Francis D ^c   Meidan, Victor ^b   Eccleston, Gillian M ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

franz cell; in vitro diffusion cell; reproducibility; standardisation; validation; variability

Indexed keywords

IBUPROFEN;

ANALYTIC METHOD; ARTICLE; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; GEL; HYDROPHOBICITY; IN VITRO STUDY; MEMBRANE PERMEABILITY; PARAMETER; PERMEABILITY BARRIER; PRIORITY JOURNAL; REPRODUCIBILITY; STATIC FRANZ DIFFUSION CELL SYSTEM; STEADY STATE; TEMPERATURE DEPENDENCE; VALIDATION PROCESS;

ABSORPTION; ADMINISTRATION, CUTANEOUS; DRUG EVALUATION, PRECLINICAL; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; MEMBRANES, ARTIFICIAL; PHARMACOKINETICS; SENSITIVITY AND SPECIFICITY; SKIN; SKIN ABSORPTION; SKIN, ARTIFICIAL; TRANSDERMAL PATCH;

EID: 78649907180     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9522-9     Document Type: Article

References (24)

1. TJ Franz 1975 Percutaneous absorption. On the relevance of in vitro data J Invest Dermatol 64 190 5 1:CAS:528:DyaE2MXhsFWktbg%3D 10.1111/1523-1747. ep12533356 123263
2. T Franz 1978 The finite dose technique as a valid in vitro model for the study of percutaneous absorption Curr Probl Dermatol 7 58 68 1:CAS:528:DyaE1MXksV2itbo%3D 752458
3. A Farinha C Toscano R Campos A Bica J Hadgraft 2003 Permeation of naproxen from saturated solutions and commercial formulations through synthetic membranes Drug Dev Ind Pharm 29 489 94 1:CAS:528:DC%2BD3sXjsFCrtbo%3D 10.1081/DDC-120018383 12737541 (Pubitemid 36528615)
4. V Shah J Elkins S Lam J Skelly 1989 Determination of in vitro drug release from hydrocortisone creams Int J Pharm 53 53 9 1:CAS:528: DyaL1MXkvVCjsr0%3D 10.1016/0378-5173(89)90361-X (Pubitemid 19160339)
5. M Siewert J Dressman C Brown V Shah 2003 FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms AAPS PharmSci Tech 4 7
6. V Shah J Elkins R Williams 1999 Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products Pharm Dev Technol 4 377 85 1:CAS:528:DyaK1MXkslCrtL4%3D 10.1081/PDT-100101373 10434283 (Pubitemid 29352896)
7. R Wester H Maibach 1992 Review: percutaneous absorption of drugs Clin Pharmacokinet 23 253 66 1:CAS:528:DyaK3sXmtw%3D%3D 10.2165/00003088-199223040- 00002 1296607
8. A Michaels SK Chandrasekaran W Francis M Meredith 1975 Drug permeation through human skin: theory and in vitro experimental measurement A I Ch E J 21 985 96 1:CAS:528:DyaE2MXlvVyitbg%3D
9. A Henning UF Schaefer D Neumann 2009 Potential pitfalls in skin permeation experiments: influence of experimental factors and subsequent data evaluation Eur J Pharm Biopharm 72 324 31 1:CAS:528:DC%2BD1MXmtVOjtLk%3D 10.1016/j.ejpb.2008.07.016 18761087
10. G Khan Y Frum O Sarheed GM Eccleston VM Meidan 2005 Assessment of drug permeability distribution in two different model skins Int J Pharm 303 81 7 1:CAS:528:DC%2BD2MXhtVamsr%2FN 10.1016/j.ijpharm.2005.07.005 16102922 (Pubitemid 41318024)
11. Y Frum GM Eccleston VM Meidan 2007 Evidence that drug flux through synthetic membranes is assocated with normally distributed permeability coefficients Eur J Pharm Biopharm 67 434 9 1:CAS:528:DC%2BD2sXovFyku7k%3D 10.1016/j.ejpb.2007.03.012 17459683 (Pubitemid 47211918)
12. R Chilcott N Barai A Beezer S Brain M Brown A Bunge, et al. 2005 Inter- and intra-laboratory variation of in vitro diffusion cell measurements: an international multi-centre study using quasi-standardised methods and materials J Pharm Sci 94 632 8 1:CAS:528:DC%2BD2MXisVWhsb4%3D 10.1002/jps.20229 15666298 (Pubitemid 40476527)
13. W Diembeck H Beck F Benech-Kieffer P Courtellemont J Dupuis W Lovell, et al. 1999 Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients Food Chem Toxicol 37 191 205 1:CAS:528:DyaK1MXislensLk%3D 10.1016/S0278-6915(98)00114-8 10227743
14. E Gale J Folkes 1965 The Incorporation of glycerol and lysine into the lipid fraction of staphyloccoccus aureus Biochem J 94 390 400 1:CAS:528:DyaF2MXisVSlsw%3D%3D 14348199
15. P He S Davis L Illum 1998 In vitro evaluation of the mucoadhesive properties of chitosan microspheres Int J Pharm 166 75 68 1:CAS:528: DyaK1cXis1WqsLg%3D 10.1016/S0378-5173(98)00027-1 (Pubitemid 28239741)
16. J Skelly V Shah H Maibach R Guy R Wester GL Flynn, et al. 1987 FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies-relevance to bioavailability and bioequivalence Pharm Res 4 265 7 10.1023/A:1016428716506
17. FDA-SUPAC-SS. Guidance for Industry. SUPAC-SS non-sterile semisolid dosage forms. Scale-up and postapproval changes: chemistry, manufacturing and controls. In vitro release testing and in vivo bioequivalence documentation. 1997.
18. C Gummer R Hinz H Maibach 1987 The skin penetration cell: a design update Int J Pharm 40 101 4 10.1016/0378-5173(87)90053-6
19. A Rolland G Demichelis J Jamoule B Shroot 1992 Influence of formulation, receptor fluid, and occlusion on in vitro drug release from topical dosage forms, using an automated flow-through diffusion cell Pharm Res 9 82 8 1:CAS:528:DyaK38XptFalug%3D%3D 10.1023/A:1018935912097 1589414
20. OACW Diez-Sales M Herraez-Dominguez C Javaloyes J Hadgraft 1996 A mechanistic investigation of the in vitro human skin permeationi enhancing effect of Azone Int J Pharm 129 33 40 10.1016/0378-5173(95)04237-7 (Pubitemid 26097974)
21. SLT Gallagher T Carter C Heard 2003 Effects of membrane type and liquid/liquid phase boundary on in vitro release of Ketoprofen from gel formulations J Drug Target 11 373 9 1:CAS:528:DC%2BD3sXps1agtLw%3D 10.1080/10611860310001636890 14668058 (Pubitemid 38081341)
22. J Haigh E Smith 1994 The selection and use of natural and synthetic membranes for in vitro diffusion experiments Eur J Pharm Sci 2 311 30 1:CAS:528:DyaK2MXjt1Smtrk%3D 10.1016/0928-0987(94)90032-9
23. Scheuplein R. The Skin as a barrier. In: Jarrett A, editor. The physiology and pathophysiology of skin. London: Academic; 1978. p. 1669-92.
24. F Akomeah T Nazir G Martin M Brown 2004 Effect of heat on the percutaneous absorption and skin retention of three model penetrants Eur J Pharm Sci 21 337 45 1:CAS:528:DC%2BD2cXptFWqtw%3D%3D 10.1016/j.ejps.2003.10.025 14757507 (Pubitemid 38156171)